TheJakartaPost
Please Update your browser
Your browser is out of date, and may not be compatible with our website. A list of the most popular web browsers can be found below.
Just click on the icons to get to the download page.
Pharma firm Anges and Osaka University to begin testing coronavirus vaccine on animals
Change Size
A French National Centre for Scientific Research (CNRS) researcher holds up a test tube containing cells to be infected with Covid-19 during coronavirus vaccine research work inside the Pasteur Institute laboratories in Lille, France, on March 9, 2020. Japanese biopharmaceutical firm Anges Inc said on Tuesday that it and Osaka University had completed development of a DNA vaccine against the new coronavirus and that it would begin testing it in animals soon. (Bloomberg/Adrienne Surprenant)
J
apanese biopharmaceutical firm Anges Inc said on Tuesday that it and Osaka University had completed development of a DNA vaccine against the new coronavirus and that it would begin testing it in animals soon.
Shares of Anges surged as much as 17% in morning trade in Tokyo, compared with a 5.3% gain in the broader market.
Anges, a drug-discovery company launched out of Osaka University, announced its collaboration with the school on a coronavirus vaccine on March 5. DNA vaccines are produced using an inactivated virus and can manufactured faster than protein based vaccines, according to the company statement.
Takara Bio Co is in charge of production of the vaccine and Daicel Corp's gene-transfer technology is also being utilized, the statement said.
Global pharma companies are racing to develop vaccines and treatments for coronavirus, which has reached 350,000 cases globally and resulted in over 15,000 deaths.
In Japan, market leader Takeda Pharmaceutical Co is working on a plasma-derived therapy, while the active ingredient in Fujifilm Holdings Corp's Avigan anti-flu drug is being tested as a treatment in China.
